Article Contents ::
- 1 Details About Generic Salt :: Trimetho
- 2 Main Medicine Class:: Antiemetic and antivertigo,anticholinergic
- 3 (try-meth-oh-BEN-zuh-mide HIGH-droe-KLOR-ide) Arrestin, T-Gen, Tebamide, Ticon, Tigan, Tiject-20, Trimazide Class: Antiemetic and antivertigo/anticholinergic
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Trimetho
Main Medicine Class:: Antiemetic and antivertigo,anticholinergic
(try-meth-oh-BEN-zuh-mide HIGH-droe-KLOR-ide)
Arrestin, T-Gen, Tebamide, Ticon, Tigan, Tiject-20, Trimazide
Class: Antiemetic and antivertigo/anticholinergic
Drugs Class ::
Action Believed to directly affect medullary chemoreceptor trigger zone to inhibit nausea.
Indications for Drugs ::
Indications Prevention and treatment of nausea and vomiting.
Drug Dose ::
Route/Dosage
ADULTS: PO 250 mg tid-qid. PR 200 mg tid-qid. IM 200 mg tid-qid. CHILDREN 14–41 KG: PO 100–200 mg tid-qid. PR 100–200 mg tid-qid. CHILDREN < 14 KG: PR 100 mg tid-qid.
Contraindication ::
Contraindications Hypersensitivity to benzocaine or other local anesthetics. Suppositories contraindicated in neonates or premature infants; parenteral use contraindicated in children.
Drug Precautions ::
Precautions
Pregnancy: Safety not established. Lactation: Undetermined. Hypersensitivity: Has been reported; discontinue use of drug at first signs of sensitivity.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Hypotension (after injection). CNS: Mood depression; disorientation; headache; drowsiness; opisthotonos; izziness; seizures; coma; Parkinson-like symptoms. EENT: Blurred vision. GI: Diarrhea. HEMA: Blood dyscrasias. HEPA: Jaundice. OTHER: Local pain, burning, stinging, redness and swelling (after injection); ypersensitivity reactions; muscle cramps.
Drug Mode of Action ::
Action Believed to directly affect medullary chemoreceptor trigger zone to inhibit nausea.
Drug Interactions ::
Interactions None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Assess bowel sounds and severity of nausea and vomiting.
- Implement safety precautions, particularly during initial therapy until individual response is determined.
- Implement general comfort measures.
- Monitor response to therapy.
- Monitor I&O.
- Monitor vital signs, particularly BP.
- Monitor for potential side effects, particularly drowsiness and hypotension.
Drug Storage/Management ::
Administration/Storage
- Do not use oral route with vomiting.
- If necessary, open capsule and mix with food or liquids for administration.
- Use Z-track technique for IM administration.
- Avoid exposure to light; store at room temperature.
- Avoid freezing injectable.
Drug Notes ::
Patient/Family Education
- Instruct patient that when used for motion sickness, medication should be taken 30 min before exposure to motion.
- Advise patient to report these symptoms to physician: dizziness, yellowing of skin or eyes, muscle cramps or abnormal movements.
- Instruct patient to avoid intake of alcoholic beverages or other CNS depressants.
- Advise patient that drug may cause drowsiness or dizziness and to use caution while driving or performing tasks requiring mental alertness.